Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults

Streptococcus pneumoniae is a major cause of severe disease worldwide, particularly in the elderly population. Due to increasing life expectancy in Japan and elsewhere, an effective vaccine which offers the possibility of prolonged protection is required. Protein conjugated pneumococcal vaccines, wh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Autores principales: Shiramoto, Masanari, Hanada, Ryuzo, Juergens, Christine, Shoji, Yasuko, Yoshida, Mizuki, Ballan, Barry, Cooper, David, Gruber, William C, Scott, Daniel A, Schmoele-Thoma, Beate
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2015
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635730/
https://ncbi.nlm.nih.gov/pubmed/26176163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1030550
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares